Genetically engineered cell culture adapted infectious...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/33 (2006.01) A61K 39/12 (2006.01) C12N 7/00 (2006.01) C12N 7/01 (2006.01)

Patent

CA 2298956

The present invention relates to a method for the adaptation of infectious bursal disease viruses (IBDV) to growth in CEF cell culture. Changing the codons for amino acid residues 253 (Gln) and 284 (Ala) to 253 (His) and 284 (Thr) allowed bursa adapted Classical and Variant-E IBDV to grow in CEF cell culture. For GLS IBDV only a change of the codon for amino acid residue 284 was necessary.

La présente invention concerne un procédé pour l'adaptation du virus de la maladie de bursite infectieuse (IBDV) à la croissance en culture de cellules CEF. La modification des codons pour les résidus d'acide aminé 253 (Gin) et 284 (Ala) à 253 (His) et 284 (Thr) a permis aux bourses séreuses adaptées à la E-IBDV classique et variante de croître en culture de cellules CEF. Dans le cas de la GLS IBDV, seulement un changement de codon pour l'acide aminé 284 a été nécessaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Genetically engineered cell culture adapted infectious... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetically engineered cell culture adapted infectious..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically engineered cell culture adapted infectious... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1668477

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.